• Celerion Newsletter
Belfast - Center of Excellence for Respiratory

Celerion

committed to service excellence

Primary Navigation for Celerion

  • Home
  • About Celerion
    • Why Celerion?
    • Mission, Vision and Credo
    • Management Team
    • Who We Work With
    • Locations
    • Environmental Sustainability
  • Applied Translational Medicine
    • Key Elements of Success
  • Services
    • Global Clinical Research
      • AAHRPP Accreditation
      • Phase I and lla Studies
      • In-hospital Beds
      • Study Experience
      • Belfast – Center of Excellence for Respiratory
      • Early Cardiac Services
      • Hybrid Phase I/ECG Core Lab
      • ADME/Mass Balance
      • Microtracer Studies
      • USP <797> Clean Room
      • ClinQuick® Electronic Data Acquisition
      • Recruitment
    • Clinical Pharmacology Sciences
      • Modeling and Simulation
      • Study Design and Protocol Development
      • Data Programming
      • Biostatistics
      • Pharmacokinetics/Pharmacodynamics (PK/PD)
      • Medical Writing and Reporting
      • Streamlined Data Flow Process
    • Global Bioanalytical Services
      • Small Molecule
      • Large Molecule
      • Electronic Laboratory Notebook System
      • ADME/Mass Balance
    • Drug Development Services
      • Biopharmaceutical Development
      • Program and Project Management
      • Regulatory Affairs
  • Celerion Europe
    • Global Clinical Research
    • Clinical Pharmacology Sciences
    • Global Bioanalytical Services
    • Management Team
  • The Biosimilars Alliance
    • The Biosimilars Alliance – Overview
    • The Biosimilars Alliance – Benefits
  • Case Studies
    • Global Clinical Research
      • Responding to an Unexpectedly High Drop Rate
      • Mass Balance Study
      • Semen Clinical Trials
    • Clinical Pharmacology Sciences
      • Partnering with Biotechnology Companies
      • Partnering with Large Pharmaceutical Companies
      • Protocol Study Design and Development for Generic Studies
      • Difficult to Recruit Population
      • Consistent Database Structure for Programs of Studies
    • Global Bioanalytical Services
      • Improved Desmopressin Analysis of Clinical Samples
      • Optimized LC-MS/MS Method for New Observed Metabolite
      • Bioanalytical Support of Oncology Studies
      • High Throughput Bioanalytical Analysis
      • Partnering with Biotechnology Companies
      • Partnering with Pharmaceutical Companies
      • Development of an LC-MS/MS Peptide Method
    • Drug Development Services
      • Support of CMC to IND for Novel First-in-Class Small Molecule Drugs
      • Rapid Proof-of-Concept for Novel Drug Treatment for Rare Metabolic Disease
      • Proof-of-Concept Efficacy Clinical Study
      • European Biotechnology Company Seeking First-in-Human U.S. Clinical Study
      • Asian Biotechnology Company with CNS Compound
  • White Papers
  • Other Resources
  • News & Events
    • Press Room
    • Conferences
    • Symposia
    • Webinars
  • Participate in a Study
  • Careers
    • Message from the CEO
    • Culture
  • Spring 2013 Newsletter
  • Fall 2012 Newsletter
  • Spring 2012 Newsletter

White Papers

Celerion’s combination of experienced people, scientific excellence and state-of-the-art facilities strongly positions us as an industry leader in the conduct of early clinical research and bioanalytical studies. These white papers illustrate our team’s depth of knowledge and experience of the drug development lifecycle. Benefit from reading how Celerion develops high quality solutions that deliver results for our clients.

The Development of an Elisa Assay for the Determination of PTH (1-34) in Human Plasma (EDTA) and for the Determination of Anti-PTH (1-34) Antibodies in Human Serum

Curtis Sheldon, Richard Sukovaty, Sarah Peters
2013-05

The Development of an Elisa Assay for the Determination of Rituximab in Human Serum

Curtis Sheldon, Elizabeth Peterson, Rafiqul Islam, Richard Sukovaty, Sarah Peters
2013-04

The Development of an Elisa Assay for the Determination of Cetuximab in Human Serum

Curtis Sheldon, Elizabeth Peterson, Rafiqul Islam, Richard Sukovaty, Sarah Peters
2013-04

A High Sensitivity Dual Solid Phase Extraction LC-MS/MS Assay for the Determination of the Therapeutic Peptide Desmopressin in Human Plasma

Lars Neudert, Markus Zaugg, Petra Struwe, Simon Wood
2011-09

A TFC MS/MS Method for the Determination of the Cholinesterase Sensitive Analyte Rivastigmine in Human Plasma

Lars Neudert, Laurence Meunier, Petra Struwe, Simon Wood, Werner Meyer
2011-09

Assessment of Extract Cleanliness Using Different On-Line Clean Up Selectivities for a Turbulent Flow Chromatography (TFC) – MS/MS Method for the Determination of a Common Decongestant Agent in Human Plasma

Lars Neudert, Petra Struwe, Simon Wood
2011-09

Evaluation of Male Reproductive Safety During Clinical Development

Malle Jurima-Romet
2011-05

Biomarkers – Unlocking Value in Early Drug Development

Malle Jurima-Romet
2010-08

Validation of an LC-MS/MS Method for the Determination of Ribavirin in Human Plasma (EDTA)

Corey Ohnmacht, Curtis Sheldon, Erica Nachi, Jason Wenzl
2010-08

Method Validation of an LC-MS/MS Method for the Determination of Gemcitabine and 2′-deoxy-2′, 2′Difluorouridine (dFdU) in Tetrahydrouridine (THU)-Treated Plasma

Brandon Retke, Corey Ohnmacht, Curtis Sheldon, Elizabeth Peterson, Erica Nachi
2010-08

Managing Clinical Trial Application (CTA) Acceptability to Support Phase I Clinical Studies in the United Kingdom

Fiona McNeilly, Heimo Scheer, Sarah Roberts
2010-08

Highly Automated ECG Analysis

Joy Olbertz, William Wheeler
2010-08

The Development and Validation of Two High Through-Put Methods for the Determination of Biomarkers IFG-1 and IGFBP-3 in Human Plasma

Curtis Sheldon, Richard Sukovaty, Sarah Roby-Peters
2010-08

Determining the Preclinical Toxicokinetic Comparability for a Biosimilar Drug

Anita O'Connor, David Goblot, Elliot Offman
2010-08

How Modeling and Simulation Can Help in Obtaining More Information from a QT/QTc Study

Julie Grenier
2010-01

See also…

Scientific Poster: CORESTA 2011 – Current Trends in GLP-like Analysis

Scientific Poster: CPSA 2011 – Holy #$%@! What Have We Gotten Ourselves Into

For more information contact us

Footer Naviation

  • About
  • Locations
  • Careers
  • Request a Proposal
  • Contact
  • Privacy Policy
© 2013 Celerion